Teva announces proposed public offerings of American Depositary Shares
Teva announced it is commencing concurrent offerings totaling $6.75 billion, consisting of $3.375 billion of its American Depositary Shares , each representing one Teva ordinary share, and approximately $3.375 billion of its Mandatory Convertible Preferred Shares. November 30, 2015